β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy

OBJECTIVE: To investigate CSF biomarkers in presymptomatic and symptomatic mutation carriers with hereditary cerebral hemorrhage with amyloidosis–Dutch type (HCHWA-D), a model for sporadic cerebral amyloid angiopathy, and to determine the earliest deposited form of β-amyloid (Aβ). METHODS: HCHWA-D m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurology
Main Authors: van Etten, Ellis S., Verbeek, Marcel M., van der Grond, Jeroen, Zielman, Ronald, van Rooden, Sanneke, van Zwet, Erik W., van Opstal, Anna M., Haan, Joost, Greenberg, Steven M., van Buchem, Mark A., Wermer, Marieke J.H., Terwindt, Gisela M.
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5224714/
https://ncbi.nlm.nih.gov/pubmed/27903811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003486
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares